1. Home
  2. KYMR vs RNG Comparison

KYMR vs RNG Comparison

Compare KYMR & RNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • RNG
  • Stock Information
  • Founded
  • KYMR 2015
  • RNG 1999
  • Country
  • KYMR United States
  • RNG United States
  • Employees
  • KYMR N/A
  • RNG N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • RNG EDP Services
  • Sector
  • KYMR Health Care
  • RNG Technology
  • Exchange
  • KYMR Nasdaq
  • RNG Nasdaq
  • Market Cap
  • KYMR 3.1B
  • RNG 2.8B
  • IPO Year
  • KYMR 2020
  • RNG 2013
  • Fundamental
  • Price
  • KYMR $43.51
  • RNG $31.95
  • Analyst Decision
  • KYMR Strong Buy
  • RNG Hold
  • Analyst Count
  • KYMR 15
  • RNG 15
  • Target Price
  • KYMR $58.53
  • RNG $31.71
  • AVG Volume (30 Days)
  • KYMR 722.6K
  • RNG 1.8M
  • Earning Date
  • KYMR 10-30-2025
  • RNG 08-05-2025
  • Dividend Yield
  • KYMR N/A
  • RNG N/A
  • EPS Growth
  • KYMR N/A
  • RNG N/A
  • EPS
  • KYMR N/A
  • RNG N/A
  • Revenue
  • KYMR $44,711,000.00
  • RNG $2,455,731,000.00
  • Revenue This Year
  • KYMR $58.45
  • RNG $5.82
  • Revenue Next Year
  • KYMR N/A
  • RNG $5.24
  • P/E Ratio
  • KYMR N/A
  • RNG N/A
  • Revenue Growth
  • KYMR N/A
  • RNG 6.47
  • 52 Week Low
  • KYMR $19.45
  • RNG $20.59
  • 52 Week High
  • KYMR $53.27
  • RNG $42.19
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 53.28
  • RNG 63.71
  • Support Level
  • KYMR $39.84
  • RNG $29.57
  • Resistance Level
  • KYMR $43.43
  • RNG $31.42
  • Average True Range (ATR)
  • KYMR 2.03
  • RNG 0.95
  • MACD
  • KYMR 0.15
  • RNG 0.04
  • Stochastic Oscillator
  • KYMR 78.76
  • RNG 100.00

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About RNG RingCentral Inc.

RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.

Share on Social Networks: